Current NDC auxiliary source row compounder:536

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72934-5537
Product Ndc: 72934-5537
Product Ndc Digits: 729345537
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Nobela
Proprietary Name Suffix: LP
Nonproprietary Name: 201034 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%
Dosage Form Name: OINTMENT
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: SKNV
Establishment Name: SKNV
Establishment Fei: [empty]
Substance Name: LIDOCAINE; TETRACAINE; BENZOCAINE
Active Ingredients Info: 8 g/100 g; 4 g/100 g; 20 g/100 g
History Active Ingredients Raw: LIDOCAINE; TETRACAINE; BENZOCAINE
History Active Ingredients Info Raw: 8 g/100 g; 4 g/100 g; 20 g/100 g
History Dosage Raw: OINTMENT
Dea Schedule: [empty]
Package Ndc Raw: 72934-5537-4
Package Ndc: 72934-5537-4
Package Ndc Digits: 7293455374
Package Ndc11: 72934553704
Package Description: 100 g in 1 BOTTLE, PUMP (72934-5537-4)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:536
Source Row Number: 536
Source Row Hash: 2ed7bac6edd9bf38c492e87f98b69774831000dc7b4fb844310629e9d75ea9b0
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "72934-5537",
    "DEASCHEDULE": "",
    "LABELERNAME": "SKNV",
    "SUBSTANCENAME": "LIDOCAINE; TETRACAINE; BENZOCAINE",
    "DOSAGEFORMNAME": "OINTMENT",
    "NDCPACKAGECODE": "72934-5537-4",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Nobela",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "201034 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%",
    "PACKAGEDESCRIPTION": "100 g in 1 BOTTLE, PUMP (72934-5537-4) ",
    "ACTIVEINGREDIENTSINFO": "8 g/100 g; 4 g/100 g; 20 g/100 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": "LP"
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:536
Source Row Number: 536
Status Scope: package
Lookup Ndc: 72934-5537-4
Lookup Ndc Digits: 7293455374
Product Ndc: 72934-5537
Product Ndc Digits: 729345537
Package Ndc: 72934-5537-4
Package Ndc Digits: 7293455374
Package Ndc11: 72934553704
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 2ed7bac6edd9bf38c492e87f98b69774831000dc7b4fb844310629e9d75ea9b0
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20